Provenance Wealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $290K | Sell |
2,614
-25
| -0.9% | -$2.77K | 0.04% | 93 |
|
|
2025
Q1 | $296K | Sell |
2,639
-1,559
| -37% | -$175K | 0.04% | 103 |
|
|
2024
Q4 | $388K | Sell |
4,198
-12,372
| -75% | -$1.14M | 0.05% | 104 |
|
|
2024
Q3 | $1.39M | Buy |
16,570
+426
| +3% | +$35.7K | 0.17% | 50 |
|
|
2024
Q2 | $1.11M | Buy |
16,144
+472
| +3% | +$32.4K | 0.15% | 55 |
|
|
2024
Q1 | $1.15M | Buy |
15,672
+445
| +3% | +$32.6K | 0.16% | 53 |
|
|
2023
Q4 | $1.23M | Buy |
15,227
+220
| +1% | +$17.8K | 0.17% | 43 |
|
|
2023
Q3 | $1.12M | Buy |
+15,007
| New | +$1.12M | 0.18% | 41 |
|